Organon (OGN) Profit After Tax (2020 - 2026)
Organon (OGN) recorded quarterly Profit After Tax of $146.0 million in Q1 2026, up 171.22% quarter-over-quarter from -$205.0 million in Q4 2025, and up 67.82% on a YoY basis from $87.0 million in Q1 2025.
Organon (OGN) Profit After Tax (2020 - 2026) Analysis & Trends
Organon's Profit After Tax history runs 7 years deep, the most recent figure standing at $146.0 million for Q1 2026.
- In Q1 2026, Profit After Tax rose 67.82% year-over-year to $146.0 million; the TTM figure through Mar 2026 stood at $246.0 million (down 67.2% YoY), while the FY2025 annual figure was $187.0 million, down 78.36% from the prior year.
- Profit After Tax was $146.0 million for Q1 2026 at Organon, up from -$205.0 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $546.0 million in Q4 2023 to a low of -$205.0 million in Q4 2025.
- Historically, Profit After Tax has averaged $184.5 million across 5 years, with a median of $177.0 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Profit After Tax jumped 518.97% in 2024, then sank 288.07% in 2025.
- A 5-year view of Profit After Tax shows it stood at $108.0 million in 2022, then soared by 405.56% to $546.0 million in 2023, then plunged by 80.04% to $109.0 million in 2024, then tumbled by 288.07% to -$205.0 million in 2025, then jumped by 171.22% to $146.0 million in 2026.
- The last three Profit After Tax figures came in at $146.0 million (Q1 2026), -$205.0 million (Q4 2025), and $160.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,134,969.93 Bn | 92,134,964.97 Bn | 7.76 Bn | 2.48 Bn |
| 2 | Eli Lilly | 1,027.45 Bn | 1,022.17 Bn | 16.22 Bn | 7.40 Bn |
| 3 | Johnson & Johnson | 559.08 Bn | 537.03 Bn | 15.96 Bn | 5.24 Bn |
| 4 | AbbVie | 394.75 Bn | 385.40 Bn | 10.78 Bn | 697.00 Mn |
| 5 | Merck | 295.12 Bn | 289.47 Bn | 12.09 Bn | -4.24 Bn |
| 6 | Amgen | 186.65 Bn | 174.61 Bn | 5.87 Bn | 1.82 Bn |
| 7 | Gilead Sciences | 159.22 Bn | 151.50 Bn | 5.52 Bn | 2.02 Bn |
| 8 | Pfizer | 146.00 Bn | 133.23 Bn | -1.21 Bn | 2.71 Bn |
| 9 | Bristol Myers Squibb | 113.22 Bn | 102.77 Bn | 8.07 Bn | 2.68 Bn |
| 10 | Organon | 3.49 Bn | 2.37 Bn | 783.00 Mn | 146.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 146.00 Mn |
| Dec 31, 2025 | -205.00 Mn |
| Sep 30, 2025 | 160.00 Mn |
| Jun 30, 2025 | 145.00 Mn |
| Mar 31, 2025 | 87.00 Mn |
| Dec 31, 2024 | 109.00 Mn |
| Sep 30, 2024 | 359.00 Mn |
| Jun 30, 2024 | 195.00 Mn |
| Mar 31, 2024 | 201.00 Mn |
| Dec 31, 2023 | 546.00 Mn |
| Sep 30, 2023 | 58.00 Mn |
| Jun 30, 2023 | 242.00 Mn |
| Mar 31, 2023 | 177.00 Mn |
| Dec 31, 2022 | 108.00 Mn |
| Sep 30, 2022 | 227.00 Mn |
| Jun 30, 2022 | 234.00 Mn |
| Mar 31, 2022 | 348.00 Mn |
| Dec 31, 2021 | 202.00 Mn |
| Sep 30, 2021 | 323.00 Mn |
| Jun 30, 2021 | 431.00 Mn |